These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8822599)

  • 21. Allelic discrimination of factor V Leiden using a 5' nuclease assay.
    Happich D; Schwaab R; Hanfland P; Hoernschemeyer D
    Thromb Haemost; 1999 Oct; 82(4):1294-6. PubMed ID: 10544916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
    Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
    Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
    Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays.
    Galli M; Duca F; Ruggeri L; Finazzi G; Negri B; Moia M
    Thromb Haemost; 1998 Aug; 80(2):246-9. PubMed ID: 9716147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
    Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
    Benattar N; Schved JF; Biron-Andréani C
    Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
    [No Abstract]   [Full Text] [Related]  

  • 27. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].
    Hakala L; Vahtera E; Krusius T; Rasi V
    Duodecim; 1995; 111(22):2143-51. PubMed ID: 9841174
    [No Abstract]   [Full Text] [Related]  

  • 29. Detecting APC-resistant factor V: a functional method without plasma dilution.
    Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arg506 to Gln mutation in the factor V gene causes poor fibrinolytic response in children after venous occlusion.
    Nowak-Göttl U; Binder M; Dübbers A; Kehrel B; Koch HG; Veltmann H; Vielhaber H
    Thromb Haemost; 1997 Sep; 78(3):1115-8. PubMed ID: 9308763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of activated protein C resistance during menstrual cycle in women with and without the Leiden mutation.
    Wramsby ML; Bremme K; Blombäck M
    Thromb Haemost; 2001 Apr; 85(4):614-8. PubMed ID: 11341494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of the FVQ506 mutation in the Hellenic population.
    Chaida C; Gialeraki A; Tsoukala C; Mandalaki T
    Thromb Haemost; 1996 Jul; 76(1):127. PubMed ID: 8819267
    [No Abstract]   [Full Text] [Related]  

  • 33. Fiber optic immunosensors for cardiovascular disease diagnosis: quantification of Protein C, Factor V Leiden, and cardiac Troponin T in plasma.
    Kwon HJ; Peiper SC; Kang KA
    Adv Exp Med Biol; 2003; 510():115-9. PubMed ID: 12580414
    [No Abstract]   [Full Text] [Related]  

  • 34. Priapism revealing ARG 506 to GLN factor V mutation.
    de Prost D; Delmas V; Lefebvre M; Lacombe C; Bridey F
    J Urol; 1996 Apr; 155(4):1392. PubMed ID: 8632589
    [No Abstract]   [Full Text] [Related]  

  • 35. Response to activated protein C and cerebrovascular disease.
    Jones MP; Alving B
    Ann Intern Med; 1997 May; 126(10):832-3. PubMed ID: 9148671
    [No Abstract]   [Full Text] [Related]  

  • 36. A simple method for Factor V assay.
    Hoffman ME
    Am J Med Technol; 1967; 33(4):281-4. PubMed ID: 6058720
    [No Abstract]   [Full Text] [Related]  

  • 37. [Levels of factor V in liver disease].
    Balkuv S; Ulutin ON; Barlas O
    Tip Fak Mecm; 1966; 29(3):424-31. PubMed ID: 5966835
    [No Abstract]   [Full Text] [Related]  

  • 38. [Preparation of factor V source from hypoprothrombin serum].
    Yasui T; Fujimaki M
    Rinsho Byori; 1967 Oct; 15(10):697-8. PubMed ID: 5627484
    [No Abstract]   [Full Text] [Related]  

  • 39. Factor V and siliconized glassware.
    Wilbourn RL; Bairrington JB
    Am J Med Technol; 1967; 33(6):525-6. PubMed ID: 6078847
    [No Abstract]   [Full Text] [Related]  

  • 40. [Factor V].
    Fukutake K; Fukue H
    Nihon Rinsho; 1999 Sep; 57 Suppl():597-9. PubMed ID: 10543188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.